News for ASSEMBLY BIOSCIENCES (V7B1.BE)

SOUTH SAN FRANCISCO, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology compan...

SOUTH SAN FRANCISCO, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing

SOUTH SAN FRANCISCO, Calif., March 05, 2021 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company developing ...

During Friday's morning session, 88 stocks hit new 52-week lows. Significant Points: The largest company in terms of market cap to set a ...

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 4) ...

The following slide deck was published by Assembly Biosciences, Inc.

Assembly Biosciences, Inc. (NASDAQ:ASMB) Hepatitis B Program Update Conference Call February 25, 2021 5:00 PM ET Company Participants Lauren Glaser - Senior Vice President of Investor...

Assembly Biosciences Inc (NASDAQ: ASMB) will not initiate Phase 3 studies of vebicorvir (VBR, or ABI-H0731) as a chronic suppressive ...

Assembly Biosciences (ASMB) delivered earnings and revenue surprises of -23.33% and -72.46%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Gainers ChromaDex (NASDAQ:CDXC) shares moved upwards by 22.73% to $23.0 during Thursday's after-market session. At the close, ChromaDex's trading ...

Below we presented the list of 5 best small-cap biotech stocks under $10 in 2021. For our detailed discussion as well as a more comprehensive list please...